Copper catalyzed cycloaddition for the synthesis of non isomerisable 2' and 3'-regioisomers of arg-tRNA


Journal

Methods (San Diego, Calif.)
ISSN: 1095-9130
Titre abrégé: Methods
Pays: United States
ID NLM: 9426302

Informations de publication

Date de publication:
02 Jun 2024
Historique:
received: 16 04 2024
revised: 29 05 2024
accepted: 30 05 2024
medline: 5 6 2024
pubmed: 5 6 2024
entrez: 4 6 2024
Statut: aheadofprint

Résumé

In this report, non-isomerisable analogs of arginine tRNA (Arg-triazole-tRNA) have been synthesized as tools to study tRNA-dependent aminoacyl-transferases. The synthesis involves the incorporation of 1,4 substituted-1,2,3 triazole ring to mimic the ester bond that connects the amino acid to the terminal adenosine in the natural substrate. The synthetic procedure includes (i) a coupling between 2'- or 3'-azido-adenosine derivatives and a cytidine phosphoramidite to access dinucleotide molecules, (ii) Cu-catalyzed cycloaddition reactions between 2'- or 3'-azido dinucleotide in the presence of an alkyne molecule mimicking the arginine, providing the corresponding Arg-triazole-dinucleotides, (iii) enzymatic phosphorylation of the 5'-end extremity of the Arg-triazole-dinucleotides with a polynucleotide kinase, and (iv) enzymatic ligation of the 5'-phosphorylated dinucleotides with a 23-nt RNA micro helix that mimics the acceptor arm of arg-tRNA or with a full tRNA

Identifiants

pubmed: 38834165
pii: S1046-2023(24)00142-7
doi: 10.1016/j.ymeth.2024.05.017
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yusif Afandizada (Y)

Université Paris Cité, CNRS, Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, F-75006 Paris, France.

Thilini Abeywansha (T)

Department of Biochemistry, Case Western Reserve University, Cleveland, OH 44106, USA.

Vincent Guerineau (V)

Université Paris-Saclay, CNRS, Institut de Chimie des Substances Naturelles, UPR 2301, 91198 Gif-sur-Yvette, France.

Yi Zhang (Y)

Department of Biochemistry, Case Western Reserve University, Cleveland, OH 44106, USA.

Bruno Sargueil (B)

Université Paris Cité, CNRS, UMR 8038/CiTCoM, F-75006 Paris, France.

Luc Ponchon (L)

Université Paris Cité, CNRS, UMR 8038/CiTCoM, F-75006 Paris, France. Electronic address: luc.ponchon@u-paris.fr.

Laura Iannazzo (L)

Université Paris Cité, CNRS, Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, F-75006 Paris, France. Electronic address: laura.iannazzo@u-paris.fr.

Mélanie Etheve-Quelquejeu (M)

Université Paris Cité, CNRS, Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, F-75006 Paris, France. Electronic address: etheve-Quelquejeu@u-paris.fr.

Classifications MeSH